Heart Failure Clinical Trial
RecoverLINK Technology Pilot for HF Patients
Summary
The primary objective is to examine feasibility of incorporating RecoverLINK into the standard of care as a function of (i) user engagement, (ii) user satisfaction, and (iii) workflow efficiency. As secondary objectives, the investigators will collect preliminary data to examine the association between patient engagement with the RecoverLINK app and (i) changes in patient knowledge and behavior, and (ii) hospital readmission(s) at 30, 60, and 90-day time periods post-enrollment.
Eligibility Criteria
Inclusion Criteria:
Heart failure (HF) patients with a rapid follow up appointment scheduled at the Mount Sinai HF clinic
English-speaking
With either access to (i) an iOS smart device or (ii) wifi at-home
Exclusion Criteria:
Patients meeting any of the following criteria:
A heart transplant
A mechanical circulatory support (MCS) device
An altered mental status
Serious co-morbidities (as identified by Mount Sinai team)
Cognitive impairments (as identified by Mount Sinai team)
Inability to use technology (as identified by Mount Sinai team)
Check Your Eligibility
Let’s see if you might be eligible for this study.
What is your age and gender ?
There is 1 Location for this study
New York New York, 10029, United States
How clear is this clinincal trial information?
Please confirm you are a US based health care provider:
Yes, I am a health care Provider No, I am not a health care providerSign Up Now.
Take Control of Your Disease Journey.
Sign up now for expert patient guides, personalized treatment options, and cutting-edge insights that can help you push for the best care plan.